NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Bolen S, Wilson L, Vassy J, et al. Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Jul. (Comparative Effectiveness Reviews, No. 8.)
Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes [Internet].
Show details
Figure 1b. Meta-analysis of post-treatment difference in hemoglobin A1c between rosiglitazone and placebo/diet in patients with type 2 diabetes
Figure 1c. Meta-analysis of post-treatment difference in hemoglobin A1c between metformin and placebo/diet in patients with type 2 diabetes
Figure 1d. Meta-analysis of post-treatment difference in hemoglobin A1c between second generation sulfonylureas and placebo/diet in patients with type 2 diabetes
Figure 1e. Meta-analysis of post-treatment difference in hemoglobin A1c between repaglinide and placebo/diet in patients with type 2 diabetes
Figure 1f. Meta-analysis of post-treatment difference in hemoglobin A1c between nateglinide and placebo/diet in patients with type 2 diabetes
Figure 2b. Meta-analysis of post-treatment difference in weight between rosiglitazone and placebo/diet in patients with type 2 diabetes
Figure 2c. Meta-analysis of post-treatment difference in weight between metformin and placebo/diet in patients with type 2 diabetes
Figure 2d. Meta-analysis of post-treatment difference in weight between second generation sulfonylurea and placebo/diet in patients with type 2 diabetes
Figure 2e. Meta-analysis of post-treatment difference in weight between alpha-glucosidase inhibitors and placebo/diet in patients with type 2 diabetes
Figure 3b. Meta-analysis of post-treatment difference in systolic blood pressure effect between metformin and placebo/diet in patients with type 2 diabetes
Figure 4b. Meta-analysis of post-treatment difference in low density lipoprotein effect between rosiglitazone and placebo/diet in patients with type 2 diabetes
Figure 4c. Meta-analysis of post-treatment difference in low density lipoprotein effect between metformin and placebo/diet in patients with type 2 diabetes
Figure 5b. Meta-analysis of post-treatment difference in triglycerides between rosiglitazone and placebo/diet in patients with type 2 diabetes
Figure 5c. Meta-analysis of post-treatment difference in triglycerides between metformin and placebo/diet in patients with type 2 diabetes
Figure 6a. Incidence of subjects with hypoglycemia in randomized controlled trials comparing pioglitazone with placebo/diet
Figure 6b. Incidence of subjects with hypoglycemia in randomized controlled trials comparing rosiglitazone with placebo/diet
Figure 6c. Incidence of subjects with hypoglycemia in randomized controlled trials comparing metformin with placebo/diet
Figure 6d. Incidence of subjects with hypoglycemia in randomized controlled trials comparing second generation sulfonylureas with placebo/diet
Figure 6e. Incidence of subjects with hypoglycemia in randomized controlled trials comparing repaglinide with placebo/diet
- Placebo-Controlled Meta-Analyses - Comparative Effectiveness and Safety of Oral ...Placebo-Controlled Meta-Analyses - Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes
- Analytic Framework - Improving Cultural Competence to Reduce Health DisparitiesAnalytic Framework - Improving Cultural Competence to Reduce Health Disparities
- Quality Assessments From Nelson Report - Menopausal Symptoms: Comparative Effect...Quality Assessments From Nelson Report - Menopausal Symptoms: Comparative Effectiveness of Therapies
- List of Excluded Studies - Stroke Prevention in Patients With Atrial Fibrillatio...List of Excluded Studies - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update
- Evidence Tables for Sublingual Immunotherapy Versus Subcutaneous Immunotherapy -...Evidence Tables for Sublingual Immunotherapy Versus Subcutaneous Immunotherapy - Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review
Your browsing activity is empty.
Activity recording is turned off.
See more...